Challenges for nursing human resources

Cassiani, Sílvia Helena De Bortoli

doi:10.1590/s0104-11692013000700001

Cited by 3 publications

(12 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The WHO and FIGO recommend the use of intravenous oxytocin for this purpose in all pregnant women, since it is possible to prevent at least half of the cases of PPH, and reduce its severity. 2 , 7 , 10 Although there are recommendations for the prophylactic use of misoprostol, in the hospital of this study, there was no protocol established for this purpose, since there were other oxytocic drugs available (oxytocin and ergometrine) that had greater evidence to be used as first-line treatment. 2 , 29…”

Section: Discussionmentioning

confidence: 99%

“…The more delayed the actions to control bleeding, the greater the blood loss and, consequently, the risk of coagulopathy, which may lead to hysterectomy, increased morbidity, hypovolemic shock, and maternal death. 2…”

Section: Discussionmentioning

confidence: 99%

“…1 In Brazil, bleeding is the second leading cause of maternal death, and PPH accounts for 40.8% of total number of obstetric hemorrhages. 2…”

Section: Introductionmentioning

confidence: 99%

“…4 If PPH occurs consequent to uterine atony, the initial treatment consists of uterine massage, followed by use of oxytocic agents, such as oxytocin, ergometrine, prostaglandins, and analogs. 2…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach

Koch¹,

Rattmann²

2019

Einstein (São Paulo)

View full text Add to dashboard Cite

Objective To characterize the use of the drug misoprostol for treatment of postpartum hemorrhage in pregnant women.Methods A descriptive observational study was carried out with secondary data from pregnant women who used misoprostol to treat postpartum hemorrhage in a reference public maternity, from July 2015 to June 2017. Clinical and sociodemographic profiles of pregnant women, how misoprostol was used and success rate in controling postpartum hemorrhage were characterized.Results A total of 717 prescriptions of misoprostol were identified. Of these, 10% were for treatment of postpartum hemorrhage. The majority of pregnant women were young adults, married, with complete high school education, white, residing in urban areas, multiparous (68.1%) and 25% had previous cesarean sections. The mean gestational age was 39 weeks and 51.4% had a cesarean section. There was prophylactic use of oxytocin in 47.2% of women. Treatment of postpartum hemorrhage was successful in 84.7% of women. Of these, 79.2% also used oxytocin and 54.2% methylergonovine. Only 13.5% of pregnant women had less than five prenatal visits, and the main cause of postpartum hemorrhage was uterine atony. There were 13 complications after hemorrhage, 15.3% required blood transfusion and there was one case of maternal death.Conclusion Misoprostol showed to be effective and safe for treating postpartum hemorrhage.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“…1 In Brazil, bleeding is the second leading cause of maternal death, and PPH accounts for 40.8% of total number of obstetric hemorrhages. 2…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach

Koch¹,

Rattmann²

2019

Einstein (São Paulo)

View full text Add to dashboard Cite

show abstract

“…In research, our main challenge is to "approximate scientific evidence to professional practice" (2) . Two important aspects need to be highlighted in this challenge.…”

mentioning

confidence: 99%

Coping with crack consumption

Galera

2013

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

In Brazil and in Latin American countries, since the end of the 1980's, information about crack consumption has been published and has recently resulted in the adoption of strategic measures by some governments and institutions, aiming to cope with and prevent its use.This drug consists of a mixture of basic cocaine paste with sodium bicarbonate.Its effects are that intense that users' behavior becomes exclusively centered on its consumption, forgetting about human needs like sleep, eating, sense of responsibility and survival.Nowadays, the use of care has been identified among adolescents, adults and elderly people. The usage styles and culture confront these people with countless risk situations, such as sexually transmitted diseases, unwanted pregnancy, violent acts, robberies and drug traffic.The implications of crack use represent an important problem for public health policies, for teaching and research about the clinical practice of healthcare professionals and particularly for nursing professionals, who are the most numerous categories in the health team.In Brazil, in 2010, the Ministry of Health established the Integrated Plan for Coping with Crack and Other Drugs, aiming for usage prevention, treatment and social reinsertion of users and professional training, departing from the premise that crack users are entitled to health and to reestablishing their life project. It is highlighted that this program also comprises coping with the traffic of other illegal drugs (1) .The plan proposes the structuring, expansion and strengthening of healthcare and social service networks for users of crack and other drugs, through the articulation between the Unified Health System -SUS' actions and those of the Unified Social Service System -SUAS, involving the participation of family members and attention to vulnerable publics, including children, adolescents and street populations.As regards professional preparation, the increasing availability of courses and training for health and education professionals is observed, as well as the introduction of contents about drug use in undergraduate programs in nursing and other health areas.In research, our main challenge is to "approximate scientific evidence to professional practice" (2) . Two important aspects need to be highlighted in this challenge. The first is the actual production of scientific evidence about our practice or our intervention. The second relates to how to turn practice into evidence in all professional practice contexts.What impedes or inhibits the transfer of useful knowledge to clinical nursing practice? Countless factors contribute to this challenging gap between theory and practice, including organizational and social processes in clinical contexts, the nature and level of evidence, the applicability and utility of the knowledge produced for clinical practice and the nurses' lack of knowledge and skills (3) . In that sense, we invite researchers who discuss the phenomenon of crack and other drugs to publish their research results in order to contri...

show abstract